LabCorp is Scheduled to Present at the 2019 Barclays Global Healthcare Conference

BURLINGTON, N.C.–(BUSINESS WIRE)–LabCorp® (NYSE: LH) today announced it will participate at the 2019
Barclays Global Healthcare Conference. LabCorp’s presentation is planned
for Tuesday, March 12, 2019, at 8:30 a.m. (ET).

A live audio webcast of the presentation will be available via the
Company website at www.LabCorp.com
and archived for replay.

About LabCorp

LabCorp (NYSE: LH), an S&P 500 company, is a leading global life
sciences company that is deeply integrated in guiding patient care,
providing comprehensive clinical laboratory and end-to-end drug
development services. With a mission to improve health and improve
lives, LabCorp delivers world-class diagnostic solutions, brings
innovative medicines to patients faster, and uses technology to improve
the delivery of care. LabCorp reported revenues of more than $11 billion
in 2018. To learn more about LabCorp, visit www.LabCorp.com,
and to learn more about Covance Drug Development, visit www.Covance.com.

Forward-Looking Statements

This press release contains forward-looking statements including but
not limited to statements with respect to estimated 2019 guidance and
the related assumptions, the impact of various factors on operating and
financial results, expected savings and synergies (including from the
LaunchPad initiative and from acquisitions), and the opportunities for
future growth. Each of the forward-looking statements is subject to
change based on various important factors, including without limitation,
competitive actions and other unforeseen changes and general
uncertainties in the marketplace, changes in government regulations,
including healthcare reform, customer purchasing decisions, including
changes in payer regulations or policies, other adverse actions of
governmental and third-party payers, changes in testing guidelines or
recommendations, adverse results in material litigation matters, the
impact of changes in tax laws and regulations, failure to maintain or
develop customer relationships, our ability to develop or acquire new
products and adapt to technological changes, failure in information
technology, systems or data security, adverse weather conditions,
employee relations, and the effect of exchange rate fluctuations. Actual
results could differ materially from those suggested by these
forward-looking statements. The Company has no obligation to provide any
updates to these forward-looking statements even if its expectations
change. Further information on potential factors, risks and
uncertainties that could affect operating and financial results is
included in the Company’s Form 10-K for the year ended December 31,
2018, and subsequent Forms 10-Q, including in each case under the
heading RISK FACTORS, and in the Company’s other filings with the SEC.
The information in this press release should be read in conjunction with
a review of the Company’s filings with the SEC including the information
in the Company’s Form 10-K for the year ended December 31, 2018, and
subsequent Forms 10-Q, under the heading MANAGEMENT’S DISCUSSION AND
ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

Contacts

Investor Contact:
Clarissa Willett – 336-436-5076

Media Contact:
Pattie Kushner – 336-436-8263

error: Content is protected !!